433 related articles for article (PubMed ID: 12557141)
1. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
[TBL] [Abstract][Full Text] [Related]
2. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
4. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
[TBL] [Abstract][Full Text] [Related]
5. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
7. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
8. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
9. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
10. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
11. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies.
Ruiz-Ferrer M; Barroso N; Antiñolo G; Aguilar-Reina J
J Viral Hepat; 2004 Jul; 11(4):319-23. PubMed ID: 15230854
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
[TBL] [Abstract][Full Text] [Related]
15. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
[TBL] [Abstract][Full Text] [Related]
16. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
[TBL] [Abstract][Full Text] [Related]
17. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
[TBL] [Abstract][Full Text] [Related]
18. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
[TBL] [Abstract][Full Text] [Related]
19. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
Li H; Liu TJ; Hong ZH
Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
[TBL] [Abstract][Full Text] [Related]
20. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
